The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients
about
Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinedionesReview article: nuclear receptors and liver disease--current understanding and new therapeutic implications.Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
P2860
The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The effects of Thiazolidinedio ...... rophy in HIV-infected patients
@en
type
label
The effects of Thiazolidinedio ...... rophy in HIV-infected patients
@en
prefLabel
The effects of Thiazolidinedio ...... rophy in HIV-infected patients
@en
P2860
P356
P1433
P1476
The effects of Thiazolidinedio ...... rophy in HIV-infected patients
@en
P2093
Jussi Sutinen
P2860
P304
P356
10.1155/2009/373524
P577
2008-12-01T00:00:00Z